Guardant Health partners with Nuvalent for cancer diagnostics development
Go back to Guardant Health partners with Nuvalent for cancer diagnostics development| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 157.21 -2.33 (1.46%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $159.54 | 52 Week High | $5.84 | |||
| Open | $157.93 | 52 Week Low | $5.49 | |||
| Day High | $159.71 | P/E | N/A | |||
| Day Low | $156.21 | EPS | $0.00 | |||
| Volume | 2,564,774 | |||||
| Nuvel Holdings, Inc. (NASDAQ: NUVL) | Delayed: 123.96 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.96 | 52 Week High | $0.40 | |||
| Open | $123.96 | 52 Week Low | $0.14 | |||
| Day High | $123.96 | P/E | N/A | |||
| Day Low | $123.96 | EPS | $-0.56 | |||
| Volume | 66,514 | |||||
